Malaria vaccine price cut set to protect 7 million more children by 2030
A landmark agreement between Gavi and UNICEF has secured a major price reduction for the R21 malaria vaccine, lowering the cost from $3.90 to under $3 per dose. This 25% price cut is expected to save $90 million, allowing for the purchase of 30 million additional doses. This financial breakthrough accelerates the goal of vaccinating 50 million children across Africa by 2030, providing a critical new tool to save lives and reduce the burden of this deadly disease.


